A/s Novo, 10% Owner at Tobira Therapeutics, Inc. (TBRA), sold 27,133 shares at $12.58 ($341K) on 2016-06-30, disclosed to the SEC on 2016-06-30.
Open-market sale of $341k TBRA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| RETA | SELL | 2017-06-07 | $2.5M | — | Filing → |
| APEN | SELL | 2017-05-11 | $582K | — | Filing → |
| ANAB | BUY | 2017-02-01 | $750K | — | Filing → |